Total Payments
$38,406
2024 Payments
$1,674
Companies
34
Transactions
153
Medicare Patients
1,012
Medicare Billing
$168,008
Payment Breakdown by Category
Consulting$18,420 (48.0%)
Other$9,948 (25.9%)
Food & Beverage$7,870 (20.5%)
Travel$2,103 (5.5%)
Education$64.70 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,420 | 7 | 48.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,448 | 4 | 22.0% |
| Food and Beverage | $7,870 | 126 | 20.5% |
| Travel and Lodging | $2,103 | 10 | 5.5% |
| Honoraria | $1,500 | 1 | 3.9% |
| Education | $64.70 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ipsen Biopharmaceuticals, Inc | $10,323 | 25 | $0 (2024) |
| PFIZER INC. | $10,240 | 9 | $0 (2024) |
| Verastem, Inc. | $6,062 | 2 | $0 (2019) |
| Exelixis Inc. | $2,027 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $1,927 | 31 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,635 | 2 | $0 (2019) |
| Secura Bio, Inc. | $1,598 | 2 | $0 (2020) |
| Merck Sharp & Dohme LLC | $969.98 | 15 | $0 (2024) |
| GENZYME CORPORATION | $492.95 | 3 | $0 (2024) |
| BeiGene USA, Inc. | $441.34 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,674 | 39 | AstraZeneca Pharmaceuticals LP ($404.08) |
| 2023 | $883.73 | 14 | AstraZeneca Pharmaceuticals LP ($288.44) |
| 2022 | $1,195 | 16 | BeiGene USA, Inc. ($441.34) |
| 2021 | $409.24 | 7 | AstraZeneca Pharmaceuticals LP ($370.34) |
| 2020 | $4,134 | 13 | Ipsen Biopharmaceuticals, Inc ($2,351) |
| 2019 | $28,739 | 45 | PFIZER INC. ($10,220) |
| 2018 | $793.80 | 11 | Merck Sharp & Dohme Corporation ($294.93) |
| 2017 | $576.95 | 8 | Merck Sharp & Dohme Corporation ($511.83) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.38 | General |
| Category: Oncology | ||||||
| 12/09/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Oncology | ||||||
| 10/28/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $124.35 | General |
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 10/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.81 | General |
| 08/28/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: Oncology | ||||||
| 08/27/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Oncology | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $107.56 | General |
| 07/15/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: Hematology | ||||||
| 07/01/2024 | E.R. Squibb & Sons, L.L.C. | AUGTYRO (Drug) | Food and Beverage | Cash or cash equivalent | $22.29 | General |
| Category: Oncology | ||||||
| 06/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.32 | General |
| 06/05/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Oncology | ||||||
| 05/31/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $38.87 | General |
| 05/01/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 158 | 455 | $61,085 | $23,239 |
| 2022 | 7 | 219 | 718 | $126,560 | $38,355 |
| 2021 | 10 | 272 | 1,657 | $183,024 | $53,645 |
| 2020 | 14 | 363 | 2,558 | $222,266 | $52,769 |
Total Patients
1,012
Total Services
5,388
Medicare Billing
$168,008
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 87 | $25,076 | $11,317 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 77 | $16,562 | $7,092 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 50 | $7,214 | $2,778 | 38.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 29 | 157 | $6,437 | $1,195 | 18.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 84 | $5,796 | $857.60 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 112 | $30,954 | $13,921 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 114 | $23,370 | $10,169 | 43.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 13 | 56 | $38,360 | $5,753 | 15.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 59 | $11,977 | $3,044 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 49 | $6,713 | $2,725 | 40.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 36 | 210 | $7,770 | $1,610 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 118 | $7,416 | $1,134 | 15.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 38 | 133 | $37,236 | $18,196 | 48.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 114 | $23,693 | $10,755 | 45.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 94 | $64,112 | $10,477 | 16.3% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 14 | 161 | $14,647 | $3,894 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 59 | $8,167 | $3,727 | 45.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 12 | 54 | $10,962 | $2,744 | 25.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 41 | 175 | $6,475 | $1,360 | 21.0% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2021 | 14 | 62 | $10,435 | $1,333 | 12.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 105 | $6,597 | $1,073 | 16.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 12 | 700 | $700.00 | $86.02 | 12.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 66 | 195 | $39,975 | $15,611 | 39.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 20 | 126 | $86,310 | $13,235 | 15.3% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 19 | 258 | $23,478 | $6,137 | 26.1% |
About Dr. Rushir Choksi, MD
Dr. Rushir Choksi, MD is a Hematology & Oncology healthcare provider based in Butler, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1851553663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rushir Choksi, MD has received a total of $38,406 in payments from pharmaceutical and medical device companies, with $1,674 received in 2024. These payments were reported across 153 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($18,420).
As a Medicare-enrolled provider, Choksi has provided services to 1,012 Medicare beneficiaries, totaling 5,388 services with total Medicare billing of $168,008. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program, Hematology & Oncology
- Location Butler, PA
- Active Since 07/02/2008
- Last Updated 07/21/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1851553663
Products in Payments
- Copiktra (Drug) $6,062
- SOMATULINE DEPOT (Drug) $2,897
- Cabozantinib (Drug) $2,027
- PROVENGE (Drug) $1,635
- Farydak (Drug) $1,598
- KEYTRUDA (Biological) $806.76
- ELITEK (Drug) $450.00
- BRUKINSA (Drug) $441.34
- VENCLEXTA (Drug) $230.06
- Somatuline Depot (Drug) $210.71
- KRAZATI (Drug) $196.41
- CALQUENCE (Drug) $163.87
- Onivyde (Drug) $149.29
- OPDIVO (Biological) $141.92
- Vectibix (Biological) $119.80
- SUSTOL (Drug) $113.53
- KISQALI (Drug) $108.81
- DARZALEX (Biological) $105.85
- OJJAARA (Drug) $101.34
- Trodelvy (Drug) $81.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Butler
Mariya Apostolova, Md, MD
Hematology & Oncology — Payments: $7,245
Hematology & Oncology $7,245
Dr. Bushra Haq, Md, MD
Hematology & Oncology — Payments: $5,809
Hematology & Oncology $5,809
Neeta Pathe, Md, MD
Hematology & Oncology — Payments: $3,501
Hematology & Oncology $3,501
Dr. Sigurdur Petursson, Md, MD
Hematology & Oncology — Payments: $2,643
Hematology & Oncology $2,643
Dennis Dobrzynski, Md, MD
Hematology & Oncology — Payments: $1,386
Hematology & Oncology $1,386
Dr. Gloria Minella, M.d, M.D
Hematology & Oncology — Payments: $629.91
Hematology & Oncology $629.91